Current state of urological cryosurgery: Prostate and kidney: REVIEW ARTICLE

BJU International

Volumn 105, Issue 5, 2010, Pages 590-600

  Levy, David ^a   Avallone, Anthony ^a   Jones, J Stephen ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cryosurgery; Kidney; Prostate

Indexed keywords

ACUTE KIDNEY FAILURE; BLEEDING; CANCER RADIOTHERAPY; CHRONIC KIDNEY FAILURE; COLON FISTULA; CRYOABLATION; CRYOBIOLOGY; CRYOSURGERY; CRYOTHERAPY; DEEP VEIN THROMBOSIS; DISEASE FREE SURVIVAL; FOLLOW UP; HEART DISEASE; HEMATOTHORAX; HUMAN; INTESTINE OBSTRUCTION; KIDNEY CARCINOMA; KIDNEY INJURY; KIDNEY TUMOR; LUNG EMBOLISM; MORBIDITY; NEPHRECTOMY; OUTCOME ASSESSMENT; PARTIAL NEPHRECTOMY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REVIEW; SALVAGE THERAPY; URINE INCONTINENCE; UROLOGIC SURGERY;

CARCINOMA, RENAL CELL; CRYOSURGERY; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; PRACTICE GUIDELINES AS TOPIC; PROSTATIC NEOPLASMS; SALVAGE THERAPY; SURVIVAL RATE;

EID: 77149180085     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09235.x     Document Type: Review

References (96)

1. Thompson I, Thrasher JB, Aus G et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 2007 177 : 2106 2131 (Pubitemid 46726449)
2. Soanes WA, Gonder MJ, Shulman S. Apparatus and technique for cryosurgery of the prostate. J Urol 1966 96 : 508 11
3. Gonder MJ, Soanes WA, Shulman S. Cryosurgical treatment of the prostate. Invest Urol 1966 3 : 372 378
4. Loening SA, Bonney WW, Fallon B et al. Cryotherapy. Prostate 1984 5 : 199 204
5. Onik GM, Cohen JK, Reyes GD, Rubinsky B, Chang Z, Baust J. Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 1993 72 : 1291 1299
6. Lee F, Bahn DK, McHugh TA, Onik GM, Lee FT Jr. US-guided percutaneous cryoablation of prostate cancer. Radiology 1994 192 : 769 776
7. Chang Z, Finkelstein JJ, Ma H, Baust J. Development of a high-performance multiprobe cryosurgical device. Biomed Instrum Technol 1994 28 : 383 390
8. Cohen JK, Miller RJ. Thermal protection of urethra during cryosurgery of prostate cancer. Cryobiology 1994 31 : 313 316
9. Wong WS, Chinn DO, Chinn M, Chinn J, Tom WL, Tom WL. Cryosurgery as a treatment for prostate carcinoma: results and complications. Cancer 1997 79 : 963 974
10. Cohen JK, Miller RJ, Shuman BA. Urethral warming catheter for use during cryoablation of the prostate. Urology 1995 45 : 861 864
11. Zisman A, Pantuck AJ, Cohen JK, Belldegrun AS. Prostate cryoablation using direct transperineal placement of ultrathin probes through a 17-gauge brachytherapy template-technique and preliminary results. Urology 2001 58 : 988 993
12. Pisters LL, von Eschenbach AC, Scott SM et al. The efficacy and complications of salvage cryotherapy of the prostate. J Urol 1997 157 : 921 925
13. Ghafar MA, Johnson CW, De Taille A et al. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol 2001 166 : 1333 1338
14. De La Taille A, Benson MC, Bagiella E et al. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence. BJU Int 2000 85 : 281 286
15. Chin JL, Pautler SE, Mouraviev V, Touma N, Moore K, Downey DB. Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol 2001 165 : 1937 1942
16. Zacarrian SA, Stone D, Clater M. Effects of cryogenic temperatures in the microcirculation in the golden hamster cheek pouch. Cryobiology 1970 7 : 27 39
17. Baust JG, Gage AA, Clarke D, Baust JM, Van Buskirk R. Cryosurgery - a putative approach to molecular-based optimization. Cryobiology 2004 48 : 190 204
18. Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology 1998 37 : 171 186
19. Klossner DP, Baust JM, Van Buskirk RG, Gage AA, Baust JG. Cryoablative response of prostate cancer cells is influenced by androgen receptor expression. BJU Int 2008 101 : 1310 1316
20. Hollister WR, Mathew AJ, Baust JG, Van Buskirk RG. Effects of freezing on cell viability and mechanisms of cell death in a human prostate cancer cell line. Mol Urol 1998 2 : 13 8
21. Baust JG, Gage AA. The molecular basis of cryosurgery. BJU Int 2005 95 : 1187 1191
22. Roach M III., Hanks G, Thames H Jr. et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer. recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006 65 : 965 974
23. Cookson MS, Aus G, Burnett AL et al. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 2007 177 : 540 545
24. Babaian RJ, Donnelly B, Bahn D et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol 2008 180 : 1993 2004
25. Long JP, Bahn D, Lee F, Shinohara K, Chinn DO, Macaluso JN Jr. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology 2001 57 : 518 523
26. Bahn D, Lee F, Badalament R, Kumar A, Greski J, Cherniak M. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 2002 60 (Suppl. 2A 3 11
27. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiol Bio Phys 1997 37 : 1035 1041
28. Donnelly BJ, Saliken JC, Ernst DS et al. Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology 2002 60 : 645 649
29. Ellis DS. Cryosurgery as primary treatment for localized prostate cancer: a community hospital experience. Urology 2002 60 (Suppl. 2A 34 9
30. Jones JS, Rewcastle JC, Donnelly BJ, Lugnani FM, Pisters LL, Katz AE. Whole gland primary prostate cryoablation: initial results from the Cryo On-Line Data Registry. J Urol 2008 180 : 554 558
31. D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate specific antigen era. J Clin Oncol 2003 21 : 2163 2172
32. Cohen JK, Miller RJ Jr., Ahmed S, Lotz MJ, Baust J. Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy. Urology 2008 71 : 515 518
33. Shinohara K, Rhee B, Presti JC Jr., Carroll PR. Cryosurgical ablation of prostate cancer: patterns of cancer recurrence. J Urol 1997 158 : 2206 2210 (Pubitemid 27481358)
34. Benoit RM, Cohen JK, Miller RJ Jr. Cryosurgery for prostate cancer: new technology and indications. Curr Urol Rep 2000 1 : 41 7
35. Ellis DS, Manny TB Jr., Rewcastle JC. Cryoablation as a primary treatment for localized prostate cancer followed by early penile rehabilitation. Urology 2007 69 : 306 310
36. Levy DA, Pisters LL, Jones JS. Primary cryoablation nadir prostate specific antigen and biochemical failure. J Urol 2009 182 : 931 937
37. Levy DA, Li J, Jones JS. Impact of disease burden on cryoablation prostate-specific antigen outcomes. Urology 2009 Epub ahead of print]. DOI:10.1016/j.urology. 2009.09.054
38. Prepelica KL, Okeke Z, Murphy A, Katz AE. Cryosurgical ablation of the prostate: high risk patient outcomes. Cancer 2005 15 : 1625 1630
39. Han KR, Cohen JK, Miller RJ et al. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol 2003 170 : 1126 1130
40. Koppie TM, Shinohara K, Grossfeld GD, Presti JC Jr., Carroll PR. The efficacy of cryosurgical ablation of prostate cancer: the University of California, San Francisco experience. J Urol 1999 162 : 427 432
41. Wiegel T, Lohm G, Bottke D et al. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome - results of a retrospective study. Int J Radiat Oncol Biol Phys 2009 73 : 1009 1016
42. Pasquier D, Ballereau C. Adjuvant and salvage radiotherapy after prostatectomy for prostate cancer: a literature review. Int J Radiat Oncol Biol Phys 2008 72 : 972 979
43. De Meerleer G, Fonteyne V, Meersschout S et al. Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy. Radiother Oncol 2008 89 : 205 213
44. Pisters LL, Leibovici D, Blute M et al. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy. J Urol 2009 182 : 517 527
45. Leibovici D, Spiess PE, Heller L, Rodriguez-Bigas M, Chang G, Pisters LL. Salvage surgery for locally recurrent prostate cancer after radiation therapy: tricks of the trade. Urol Oncol 2008 26 : 9 16
46. Sanderson KM, Penson DF, Cai J et al. Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer. J Urol 2006 176 : 2025 2032
47. Izawa JI, Perrotte P, Greene GF et al. Local tumor control with salvage cryotherapy for locally recurrent prostate cancer after external beam radiotherapy. J Urol 2001 165 : 867 870
48. Izawa JI, Madsen LT, Scott SM et al. Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome. J Clin Oncol 2002 20 : 2664 2671
49. Spiess PE, Lee AK, Leibovici D, Wang X, Do KA, Pisters LL. Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy. Cancer 2006 107 : 275 280
50. Levy DA, Pisters LL, Jones JS. Impact of Nadir Post Salvage Cryoablation Prostate Specific Antigen Level on Biochemical Disease Free Survival. Chicago, IL : Annual Meeting American Urological Association, 2009 : Abstract 1981
51. Donnelly BJ, Saliken JC, Ernst DS et al. Role of transrectal ultrasound guided salvage cryosurgery for recurrent prostate carcinoma after radiotherapy. Prostate Cancer Prostatic Dis 2005 8 : 235 242
52. Djavan B, Susani M, Bursa B, Basharkhah A, Sinak R, Marberger M. Predictability and significance of multifocal prostate cancer in the radical prostatectomy specimen. Techniques Urol 1999 5 : 139 142
53. Villers A, McNeal JE, Freiha FS, Stamey TA. Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors. Cancer 1992 70 : 2313 2318
54. Noguchi M, Stamey TA, McNeal JE, Nolley R. Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers. J Urol 2003 170 : 459 463
55. Ward JF, Jones JS. Classification system: organ preserving treatment for prostate cancer. Urology 2009 in press
56. Onik G, Narayan P, Vaughan D, Dineen M, Brunelle R. Focal 'nerve-sparing' cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology 2002 60 : 109 114
57. Bahn DK, Silverman P, Lee F Sr., Badalament R, Bahn ED, Rewcastle JC. Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol 2006 20 : 688 692
58. Ellis DS, Manny TB Jr., Rewcastle JC. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer initial results. Urology 2007 70 (Suppl 9 15
59. Lambert EH, Bolte K, Masson P, Katz AE. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology 2007 69 : 1117 1120
60. Onik G, Vaughan D, Lotenfoe R, Dineen M. The 'male lumpectomy': focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow up. Urol Oncol 2008 26 : 500 505
61. Mathew A, Devesa SS, Fraumeni JF Jr., Chow WH. Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev 2002 11 : 171 178
62. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006 98 : 1131 1134
63. Chow W, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cancer in the United States. JAMA 1999 281 : 1628 1631
64. Rassweiler JJ, Abbou C, Janetschek G, Jeschke K. Laparoscopic partial nephrectomy. The European experience. Urol Clin North Am 2000 27 : 721 736
65. Janetschek G, Daffner P, Peschel R, Bartsch G. Laparoscopic nephron sparing surgery for small renal cell carcinoma. J Urol 1998 159 : 1152 1155
66. Leibovich BC, Blute ML, Chevelle JC, Lohse CM, Weaver AL, Zincke H. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol 2004 17 : 1066 1070 (Pubitemid 38327528)
67. Pahernik S, Roos F, Hampel C, Gillitzer R, Melchior SW, Thuroff JW. Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience. J Urol 2006 175 : 2027 2031
68. Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 2000 163 : 442 445
69. Weight CJ, Fergany AF, Gunn P, Lang BR, Novick AC. The impact of minimally invasive techniques on open partial nephrectomy: a 10-year single institutional experience. J Urol 2008 180 : 84 8
70. Hinshaw JL, Shadid AM, Nakada SY, Hedican SP, Winter TC 3rd., Lee FT Jr. Comparison of percutaneous and laparoscopic cryoablation for the treatment of solid renal masses. AJR Am J Roentgenol 2008 191 : 1159 1168
71. Finley DS, Beck S, Box G et al. Percutaneous and laparoscopic cryoablation of small renal masses. J Urol 2008 180 : 492 498
72. Chosy SG, Nakada SY, Lee FT Jr., Warner TF. Monitoring renal cryosurgery: predictors of tissue necrosis in swine. J Urol 1998 159 : 1370 1374
73. Campbell SC, Krishnamurthi V, Chow G, Hale J, Myles J, Novick AC. Renal cryosurgery: experimental evaluation of treatment parameters. Urology 1998 52 : 29 34
74. Uchida M, Imaide Y, Sugimoto K, Uehara H, Watanabe H. Percutaneous cryosurgery for renal tumors. Br J Urol 1995 75 : 132 137
75. Delworth MG, Pisters LL, Fornage BD, von Eschenbach AC. Cryotherapy for renal cell carcinoma and angiomyolipoma. J Urol 1996 155 : 252 255
76. Gill IS, Novick AC, Soble JJ et al. Laparoscopic renal cryoablation: initial clinical series. Urology 1998 52 : 543 551
77. Gill IS, Novick AC, Meraney AM et al. Laparoscopic renal cryoablation in 32 patients. Urology 2000 56 : 748 753
78. Shingleton WB, Sewell PE Jr. Percutaneous renal tumor cryoablation with magnetic resonance imaging guidance. J Urol 2001 165 : 773 776
79. Badger WJ, de Araujo HA, Kuehn DM, Angresen KJ, Winfield HN. Laparoscopic renal tumor cryoablation: appropriate application of real-time ultrasonographic monitoring. J Endourol 2009 23 : 427 430
80. Kramer BA, Whelan CM, Vestal JC, Schwartz BF. Increasing the number of biopsy cores before renal cryoablation increases the diagnostic yield. J Endourol 2009 23 : 283 286
81. Carvalhal EF, Gill IS, Meraney AM, Desai MM, Schweizer DK, Sung GT. Laparoscopic renal cryoablation. Impact on renal function and blood pressure. Urology 2001 58 : 357 361
82. Bourne AE, Kramer BA, Steiner HL, Schwartz BF. Renal insufficiency is not a contraindication for cryoablation of small renal masses. J Endourol 2009 23 : 1195 1198
83. Kawamoto S, Permpongkosol S, Bluemke DA, Fishman EK, Solomon SB. Sequential changes after radiofrequency ablation and cryoablation of renal neoplasms: role of CT and MR imaging. Radiographics 2007 27 : 343 355
84. Remer EM, Weinberg EJ, Oto A, O'Malley CM, Gill IS. MR imaging of the kidneys after laparoscopic cryoablation. AJR Am J Roentgenol 2000 174 : 635 640
85. Wile GE, Leyendecker JR, Krehbiel KA, Dyer RB, Zagoria MD. CT and MR imaging after imaging-guided thermal ablation of renal neoplasms. Radiographics 2007 27 : 325 340
86. Gill IS, Remer EM, Hasan WA et al. Renal cryoablation: outcomes at 3 years. J Urol 2005 173 : 1903 1907
87. Weight CJ, Kaouk JH, Hegarty NJ et al. Correlation of radiographic imaging and histopathology following cryoablation and radiofrequency ablation for renal tumors. J Urol 2008 179 : 1277 1283
88. Nguyen CT, Lane BR, Kaouk JM et al. Surgical salvage of renal cell carcinoma recurrence after thermal ablative therapy. J Urol 2008 180 : 104 109
89. Hinshaw JL, Shadid AM, Nakada SY, Hedican SP, Winter TC 3rd., Lee FT Jr. Comparison of percutaneous and laparoscopic cryoablation for the treatment of solid renal masses. AJR Am J Roentgenol 2008 191 : 1159 1168
90. American Urological Association. Guideline for Management of Clinical Stage 1 Renal Mass. Baltimore, MD : The American Urological Association, 2009 : Available at: http://www.auanet.org/content/guidelines-and-quality-care/ clinical-guidelines/main-reports/renalmass09.pdf. Accessed December 2009
91. Campbell SC, Novick AC, Belldegrun A et al. Guideline for management of the clinical T1 renal mass. J Urol 2009 182 : 1271 1279
92. Romero FR, Muntener M, Sulman A, Brito FA, Kavoussi LR. Hemothorax after percutaneous cryoablation of the kidney. Eur Urol 2007 51 : 841 843
93. Vanderbrink BA, Rastinehad A, Caplin D, Ost MC, Lobko I, Lee BR. Successful conservative management of colorenal fistula after percutaneous cryoablation of renal-cell carcinoma. J Endourol 2007 21 : 726 729
94. Lane BR, Moinzadeh A, Kaouk JH. Acute obstructive renal failure after laparoscopic cryoablation of multiple renal tumors in a solitary kidney. Urology 2005 65
95. Berger A, Kamoi K, Gill IS, Aron M. Cryoablation for renal tumors: current status. Curr Opin Urol 2009 19 : 138 142
96. Kunkle DA, Uzzo RG. Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer 2008 113 : 2671 2680